MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening

被引:177
作者
Koga, Yoshikatsu [1 ,2 ]
Yasunaga, Masahiro [1 ]
Takahashi, Amane [1 ]
Kuroda, Junichiro [1 ]
Moriya, Yoshihiro [3 ]
Akasu, Takayuki [3 ]
Fujita, Shin [3 ]
Yamamoto, Seiichiro [3 ]
Baba, Hideo [2 ]
Matsumura, Yasuhiro [1 ]
机构
[1] Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Investigat Treatment Div, Kashiwa, Chiba 2778577, Japan
[2] Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan
[3] Natl Canc Ctr, Dept Surg, Tokyo, Japan
关键词
FECAL OCCULT-BLOOD; CYCLOOXYGENASE-2; MESSENGER-RNA; DNA; STOOL; CELLS; COLON; MORTALITY; CLUSTER; MARKER; GROWTH;
D O I
10.1158/1940-6207.CAPR-10-0036
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To reduce the colorectal cancer (CRC) mortality rate, we have reported several CRC screening methods using colonocytes isolated from feces. Expression analysis of oncogenic microRNA (miRNA) in peripheral blood was recently reported for CRC detection. In the present study, we conducted miRNA expression analysis of exfoliated colonocytes isolated from feces for CRC screening. Two hundred six CRC patients and 134 healthy volunteers were enrolled in the study. miRNA expression of the miR-17-92 cluster, miR-21, and miR-135 in colonocytes isolated from feces as well as frozen tissues was analyzed by quantitative real-time PCR. The expression of the miR-17-92 cluster, miR-21, and miR-135 was significantly higher in CRC tissues compared with normal tissues. The exfoliated colonocytes of 197 CRC patients and 119 healthy volunteers were analyzed because of the presence of sufficient miRNA concentration. miR-21 expression did not differ significantly between CRC patients and healthy volunteers (P = 0.6). The expression of miR-17-92 cluster and miR-135 was significantly higher in CRC patients than in healthy volunteers (P < 0.0001). The overall sensitivity and specificity by using miRNA expression was 74.1% (146/197; 95% confidence interval, 67.4-80.1) and 79.0% (94/119; 95% confidence interval, 70.6-85.9), respectively. Sensitivity was dependent only on tumor location (P = 0.0001). miRNA was relatively well conserved in exfoliated colonocytes from feces both of CRC patients and healthy volunteers. miRNA expression analysis of the isolated colonocytes may be a useful method for CRC screening. Furthermore, oncogenic miRNA highly expressed in CRC should be investigated for CRC screening tests in the future. Cancer Prev Res; 3(11); 1435-42. (C) 2010 AACR.
引用
收藏
页码:1435 / 1442
页数:8
相关论文
共 42 条
[1]   Stool DNA and occult blood testing for screen detection of colorectal neoplasia [J].
Ahlquist, David A. ;
Sargent, Daniel J. ;
Loprinzi, Charles L. ;
Levin, Theodore R. ;
Rex, Douglas K. ;
Ahnen, Dennis J. ;
Knigge, Kandice ;
Lance, Peter ;
Burgart, Lawrence J. ;
Hamilton, Stanley R. ;
Allison, James E. ;
Lawson, Michael J. ;
Devens, Mary E. ;
Harrington, Jonathan J. ;
Hillman, Shauna L. .
ANNALS OF INTERNAL MEDICINE, 2008, 149 (07) :441-W81
[2]   MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J].
Asangani, I. A. ;
Rasheed, S. A. K. ;
Nikolova, D. A. ;
Leupold, J. H. ;
Colburn, N. H. ;
Post, S. ;
Allgayer, H. .
ONCOGENE, 2008, 27 (15) :2128-2136
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   DNA integrity as a potential marker for stool-based detection of colorectal cancer [J].
Boynton, KA ;
Summerhayes, IC ;
Ahlquist, DA ;
Shuber, AP .
CLINICAL CHEMISTRY, 2003, 49 (07) :1058-1065
[5]   Role of miR-143 targeting KRAS in colorectal tumorigenesis [J].
Chen, X. ;
Guo, X. ;
Zhang, H. ;
Xiang, Y. ;
Chen, J. ;
Yin, Y. ;
Cai, X. ;
Wang, K. ;
Wang, G. ;
Ba, Y. ;
Zhu, L. ;
Wang, J. ;
Yang, R. ;
Zhang, Y. ;
Ren, Z. ;
Zen, K. ;
Zhang, J. ;
Zhang, C-Y .
ONCOGENE, 2009, 28 (10) :1385-1392
[6]   Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster [J].
Dews, Michael ;
Homayouni, Asal ;
Yu, Duonan ;
Murphy, Danielle ;
Sevignani, Cinzia ;
Wentzel, Erik ;
Furth, Emma E. ;
Lee, William M. ;
Enders, Greg H. ;
T Mendell, Joshua ;
Thomas-Tikhonenko, Andrei .
NATURE GENETICS, 2006, 38 (09) :1060-1065
[7]   MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression [J].
Diosdado, B. ;
van de Wiel, Ma ;
Droste, J. S. Terhaar Sive ;
Mongera, S. ;
Postma, C. ;
Meijerink, W. J. H. J. ;
Carvalho, B. ;
Meijer, G. A. .
BRITISH JOURNAL OF CANCER, 2009, 101 (04) :707-714
[8]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[9]   The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers [J].
Guo, Chunguang ;
Sah, Jerome F. ;
Beard, Lydia ;
Willson, James K. V. ;
Markowitz, Sanford D. ;
Guda, Kishore .
GENES CHROMOSOMES & CANCER, 2008, 47 (11) :939-946
[10]   Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer [J].
Huang, Zhaohui ;
Huang, Dan ;
Ni, Shujuan ;
Peng, Zhilei ;
Sheng, Weiqi ;
Du, Xiang .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) :118-126